IBM shares rise 9% on earnings beat

IBM shares rise 9% on earnings beat


Chairman, President and CEO of IBM Arvind Krishna attends the 55th annual World Economic Forum meeting in Davos, Switzerland, on Jan. 22, 2025.

Yves Herman | Reuters

IBM reported fourth-quarter earnings on Wednesday that topped Wall Street expectations for earnings and revenue.

The shares rose as much as 10% in extended trading before giving up gains and settling at 9%.

Here is how the company did versus LSEG consensus expectations:

  • Earnings per share: $3.92 adjusted vs. $3.75 expected
  • Revenue: $17.55 billion vs. $17.54 billion expected

IBM reported $2.92 billion in net income, or $3.09 per diluted share, versus $3.29 billion, or $3.55 per share, in the year-ago period.

IBM said it expected full-year growth, adjusted for currency, of about 5%, and $13.5 billion in free cash flow in 2025.

IBM’s overall revenue rose 1% during the quarter. For the entire year, IBM’s revenue rose 1% to $62.8 billion, with software growing 8% while infrastructure revenue declined 4%.

IBM said its software segment grew 10% year over year to $7.9 billion, partially due to demand for artificial intelligence technology and strong performance from its Red Hat Linux operating system.

Revenue in IBM’s consulting division dropped 2% to $5.2 billion in the quarter.

In a statement, IBM CEO Arvind Krishna said the company has recorded $5 billion in bookings for its generative AI business, which includes sales and future sales in the company’s software and consulting division.

“We closed the year with double-digit revenue growth in Software for the quarter, led by further acceleration in Red Hat,” Krishna said in a statement. “Clients globally continue to turn to IBM to transform with AI.”

Don’t miss these insights from CNBC PRO



Source

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount
World

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

A box of Ozempic sits on a table in North Tyneside, Britain, Oct. 31, 2023. Lee Smith | Reuters Danish pharmaceutical giant Novo Nordisk said Wednesday it is trimming its growth expectations for its leading obesity and diabetes treatments as competition intensifies and pricing pressures mount in the weight loss market. Net profit for the […]

Read More
Europe to open lower as markets question tech valuations; Novo Nordisk earnings ahead
World

Europe to open lower as markets question tech valuations; Novo Nordisk earnings ahead

European stocks are expected to open lower, mirroring global declines as concerns grow over sky-high tech valuations. Source

Read More
California voters approve new U.S. House map to boost Democrats in 2026
World

California voters approve new U.S. House map to boost Democrats in 2026

California voters approved new congressional district boundaries Tuesday, delivering a victory for Democrats in the state-by-state redistricting battle that will help determine which party wins control of the U.S. House in 2026 and, with it, the power to thwart or advance President Donald Trump’s agenda. The approval of Proposition 50 gives Democrats a shot at […]

Read More